Back to Journals » Cancer Management and Research » Volume 10

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Total article views   HTML views PDF downloads Totals
8,198 Dovepress* 7,793+ 730 8,523
PubMed Central* 405 141 546
Totals 8,198 871 9,069
*Since 9 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar